Autolus Therapeutics plc

Focused on the treatment of cancer patients with precise, controlled and highly active engineered T-cell therapies. Autolus is a leader in cutting-edge T-cell therapies. Utilising advanced cell programming and manufacturing technologies, the company has established a development-stage pipeline of products for the treatment of haematological malignancies and solid tumours.